ANJ-810

N/A

Report date: 2022/03/04 09:25:48

NME

Base Information

Drug NameANJ-810

Drug Alias NameANJ-810

ClassificationOther

Mechanisms of ActionInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitors

TargetsInduced myeloid leukemia cell differentiation protein Mcl-1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesAnji Onco Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A